Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Ertumaxomab [USAN:INN]
Description: Trifunctional anti-HER2 x anti-CD3 antibody for treatment of metastatic breast cancer; in Phase I trial (5/2006). 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Apr 2019